BK通道激动剂可能会影响矩阵囊的分泌,并通过自来改善血管化
Jue Sun1, Youwei Lu1, Zixuan Li2
1Department of Geriatrics, Minhang Hospital, Fudan University, Shanghai, China.
Cardiovascular diagnosis and therapy
|September 15, 2025
概括
大导电和电压激活 (BK) 通道调节血管化 (VC). 用NS1619激活BK通道抑制了矩阵囊泡的形成,改善了VC. 这表明BK通道激动剂可以治疗VC.
科学领域:
- 心血管生物学 心血管生物学
- 离子通道生理学 离子通道生理学
- 血管医学 血管医学
背景情况:
- 血管化 (VC) 是心血管疾病的主要危险因素.
- 驱动VC的精确机制,涉及血管中的矿物沉积,仍然不完全理解.
- 大导电和电压激活 (BK) 通道在VC调节中的作用受到研究.
研究的目的:
- 研究BK通道在血管化的病变发生过程中的作用.
- 探索BK通道调制作为VC治疗策略的潜力.
主要方法:
- 主要血管光滑肌细胞 (VSMC) 和小鼠模型被用于研究VC.
- 细胞和动物接受了化剂,维生素D和BK通道激动剂NS1619.9的治疗.
- 基因和蛋白质表达,以及矩阵囊泡 (MV) 特性使用qPCR,西斑和NTA进行了分析.
主要成果:
- 在VC模型中观察到BK通道下调.
- NS1619治疗和BK通道过度表达抑制了MV的形成和分泌.
- 这导致了VSMC中VC的改进,并调节了Runx2和α-SMA表达.
- 使用3-MA抑制自会削弱NS1619.19的治疗效果.
结论:
- 在血管化过程中,BK通道起着调节作用.
- BK通道激动剂,可能通过激活自,可以抑制MV分泌并减轻VC.
- BK通道是治疗血管化的有希望的治疗标.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
1.5K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
447
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
447
Overview of Secretory Vesicles
9.3K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
9.3K
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K


